BeOne Medicines
ONC
#651
Rank
โ‚ฌ30.68 B
Marketcap
277,27ย โ‚ฌ
Share price
-2.56%
Change (1 day)
41.10%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚ฌ3.54 Billion

According to BeOne Medicines's latest financial reports the company has โ‚ฌ3.54 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BeOne Medicines - Net assets on balance sheet (from 2014 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚ฌ3.20 B0.07%
2023-12-31$โ‚ฌ3.19 B-21.69%
2022-12-31$โ‚ฌ4.08 B-24.54%
2021-12-31$โ‚ฌ5.41 B72.14%
2020-12-31$โ‚ฌ3.14 B260.19%
2019-12-31$โ‚ฌ0.87 B-43.03%
2018-12-31$โ‚ฌ1.53 B168.81%
2017-12-31$โ‚ฌ0.57 B69.97%
2016-12-31$โ‚ฌ0.33 B393.61%
2015-12-31$โ‚ฌ67.97 M220.81%
2014-12-31$โ‚ฌ21.18 M-175.56%
2013-12-31$-โ‚ฌ28.05 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Onconova Therapeutics
ONTX
โ‚ฌ5.16 M-99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚ฌ1.12 B-68.38%๐Ÿ‡บ๐Ÿ‡ธ USA